NCT04603157

Brief Summary

The purpose of this research is to evaluate if a hybrid semi-supervised remote exercise training program can reduce symptoms and improve quality of life and physical fitness in individuals with postural orthostatic tachycardia syndrome (POTS) and determine if this program is more effective than current standard of care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

October 15, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 26, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 18, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 18, 2022

Completed
Last Updated

March 15, 2022

Status Verified

March 1, 2022

Enrollment Period

2.1 years

First QC Date

October 15, 2020

Last Update Submit

March 14, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change Peak Oxygen consumption at 3 months

    peak oxygen consumption measured from maximal cardiopulmonary exercise testing

    baseline and following 3 month intervention

Secondary Outcomes (5)

  • Change in Composite Autonomic Symptom Score (COMPASS 31) at 3 months

    baseline and following 3 month intervention

  • Change in Functional Ability Score at 3 months

    baseline and following 3 month intervention

  • Change in 36-Item Short Form Health Survey questionnaire (SF-36) at 3 months

    baseline and following 3 month intervention

  • Change in heart rate with 10-min Stand test at 3 months

    baseline and following 3 month intervention

  • Change in blood volume at 3 months

    baseline and following 3 month intervention

Other Outcomes (9)

  • Change in anaerobic threshold oxygen consumption at 3 months

    baseline and following 3 month intervention

  • Change in matched workload oxygen consumption at 3 months

    baseline and following 3 month intervention

  • Change in anaerobic threshold heart rate at 3 months

    baseline and following 3 month intervention

  • +6 more other outcomes

Study Arms (2)

Standard of Care Group

NO INTERVENTION

Subject with diagnosed with postural orthostatic tachycardia syndrome will continue to follow the treatment recommendations of the primary care physician

Hybrid Exercise Training Group

EXPERIMENTAL

Subject with diagnosed with postural orthostatic tachycardia syndrome will follow a hybrid exercise training program

Behavioral: Hybrid Exercise Training

Interventions

Personalized exercise program completing at least 3 aerobic exercise sessions a week and receive eight supervised training sessions over the 3-months

Hybrid Exercise Training Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Must be 18 years old or older
  • Meet diagnosis criteria for POTS = a heart rate increase of ≥ 30bpm with supine to 10 minutes of standing or head-up tilt or heart rate exceeding 120 ppm after 10 minutes of standing or tilt without evidence of orthostatic hypertension (a fall in BP of \> 20/10 mmHg)
  • Been diagnosed with POTS ≥6 months prior to participation in the study (chronic)
  • Female subjects must not be pregnant or trying to become pregnant during duration of study participation
  • Those in exercise training group must be on stable medications for at least 1 month and medication must remain consistent for duration of study participation. For those in the standard of care group, a change in medication will be allowed within the first month following baseline testing, but then must remain consistent until 3-month testing time point.
  • Ehlers-Danlos Syndrome (EDS) patients will be included, but will target equal randomization between treatment groups

You may not qualify if:

  • Individual is not eligible if they are currently exercising, cut off \>30 minutes of structured exercise/physical activity per week. (assessed by Global Physical Activity Questionnaire)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Arizona

Scottsdale, Arizona, 85259, United States

Location

Related Links

MeSH Terms

Conditions

Postural Orthostatic Tachycardia Syndrome

Condition Hierarchy (Ancestors)

Orthostatic IntolerancePrimary DysautonomiasAutonomic Nervous System DiseasesNervous System Diseases

Study Officials

  • Courtney Wheatley-Guy, PhD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 15, 2020

First Posted

October 26, 2020

Study Start

January 1, 2020

Primary Completion

February 18, 2022

Study Completion

February 18, 2022

Last Updated

March 15, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations